FDA Turns Down Chronic Fatigue Drug

(MedPage Today) -- The FDA will require a new clinical trial of rintatolimod (Ampligen) as well as additional types of data before it will approve the drug for chronic fatigue syndrome, its manufacturer said.
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news